| For: | Saitoh O, Sugi K, Kojima K, Matsumoto H, Nakagawa K, Kayazawa M, Tanaka S, Teranishi T, Hirata I, Katsu KI. Increased prevalence of intestinal inflammation in patients with liver cirrhosis. World J Gastroenterol 1999; 5(5): 391-396 [PMID: 11819475 DOI: 10.3748/wjg.v5.i5.391] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i5/391.htm |
| Number | Citing Articles |
| 1 |
Georgios I Tsiaoussis, Stelios F Assimakopoulos, Athanassios C Tsamandas, Christos K Triantos, Konstantinos C Thomopoulos. Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications. World Journal of Hepatology 2015; 7(17): 2058-2068 doi: 10.4254/wjh.v7.i17.2058
|
| 2 |
Rohit Mehtani, Madhumita Premkumar, Shankey Garg, Kamal Kajal, Anand V. Kulkarni, Ajay K. Duseja, Radha K. Dhiman, Arka De, Nipun Verma, Sunil Taneja, Sahaj Rathi, Virendra Singh, Joy Chakma, Shiv L. Soni, Ashish Kakkar, Aastha T. Kapila, Chirag K. Ahuja, Smita Divyaveer, Dibyalochan Praharaj. Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF – An Open Label Randomized Clinical Trial. Journal of Clinical and Experimental Hepatology 2023; 13(6) doi: 10.1016/j.jceh.2023.05.015
|
| 3 |
Cristina Llorente, Bernd Schnabl. The Gut Microbiota and Liver Disease. Cellular and Molecular Gastroenterology and Hepatology 2015; 1(3) doi: 10.1016/j.jcmgh.2015.04.003
|
| 4 |
Barbara Bottazzi, Antonio Inforzato, Massimo Messa, Marialuisa Barbagallo, Elena Magrini, Cecilia Garlanda, Alberto Mantovani. The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling. Journal of Hepatology 2016; 64(6) doi: 10.1016/j.jhep.2016.02.029
|
| 5 |
Rajiv Jalan, Javier Fernandez, Reiner Wiest, Bernd Schnabl, Richard Moreau, Paolo Angeli, Vanessa Stadlbauer, Thierry Gustot, Mauro Bernardi, Rafael Canton, Agustin Albillos, Frank Lammert, Alexander Wilmer, Rajeshwar Mookerjee, Jordi Vila, Rita Garcia-Martinez, Julia Wendon, José Such, Juan Cordoba, Arun Sanyal, Guadalupe Garcia-Tsao, Vicente Arroyo, Andrew Burroughs, Pere Ginès. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013. Journal of Hepatology 2014; 60(6) doi: 10.1016/j.jhep.2014.01.024
|
| 6 |
Valentina Liakina. Antibiotic resistance in patients with liver cirrhosis: Prevalence and current approach to tackle. World Journal of Clinical Cases 2023; 11(31): 7530-7542 doi: 10.12998/wjcc.v11.i31.7530
Abstract(839) |
Core Tip(847) |
Full Article(HTML)(3549)
|
Full Article (PDF)-814K(236)
|
Full Article with Cover (PDF)-1066K(216)
|
Full Article (Word)-383K(176)
|
Full Article (XML)-214K(144)
|
Audio-948K(51)
|
Peer-Review Report-205K(158)
|
Answering Reviewers-380K(166)
|
Times Cited (9)
|
Total Visits (5508)
|
Open
|
| 7 |
Reiner Wiest. Bacterial Translocation. Bioscience and Microflora 2005; 24(3) doi: 10.12938/bifidus.24.61
|
| 8 |
Mochamad Adhiraga Pratama, Shogo Takahara, Masahiro Munakata, Minoru Yoneda. Estimation of radiocesium dietary intake from time series data of radiocesium concentrations in sewer sludge. Environment International 2018; 115 doi: 10.1016/j.envint.2018.03.009
|
| 9 |
Sirina Ekpanyapong, K. Rajender Reddy. Infections in Cirrhosis. Current Treatment Options in Gastroenterology 2019; 17(2) doi: 10.1007/s11938-019-00229-2
|
| 10 |
Chao-Wen Hsu, Chieh-Hsin Lin, Jui-Ho Wang, Hsin-Tai Wang, Wen-Chieh Ou, Tai-Ming King. Acute rectocolitis following endoscopy in health check-up patients—glutaraldehyde colitis or ischemic colitis?. International Journal of Colorectal Disease 2009; 24(10) doi: 10.1007/s00384-009-0764-5
|
| 11 |
Anatol Panasiuk, Jolanta Wysocka, Elzbieta Maciorkowska, Bozena Panasiuk, Danuta Prokopowicz, Janusz Zak, Karol Radomski. Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis. World Journal of Gastroenterology 2005; 11(48): 7661-7665 doi: 10.3748/wjg.v11.i48.7661
|
| 12 |
Ashwini Karthikeyan, Pazhanivel Mohan, Palanivel Chinnakali, Balasubramaniyan Vairappan. Elevated systemic zonula occludens 1 is positively correlated with inflammation in cirrhosis. Clinica Chimica Acta 2018; 480 doi: 10.1016/j.cca.2018.02.017
|
| 13 |
Zora Teltschik, Reiner Wiest, Julia Beisner, Sabine Nuding, Claudia Hofmann, Juergen Schoelmerich, Charles L. Bevins, Eduard F. Stange, Jan Wehkamp. Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense. Hepatology 2012; 55(4) doi: 10.1002/hep.24789
|
| 14 |
Kirsten E. Pijls, Daisy M.A.E. Jonkers, Montserrat Elizalde, Marie-Jose Drittij-Reijnders, Guido R. Haenen, Aalt Bast, Ad A.M. Masclee, Ger H. Koek. Is intestinal oxidative stress involved in patients with compensated liver cirrhosis?. Annals of Hepatology 2016; 15(3) doi: 10.5604/16652681.1198816
|
| 15 |
Sundhar Mohandas, Balasubramaniyan Vairappan. Ginkgolide-A attenuates bacterial translocation through activating PXR and improving antimicrobial peptide Reg 3A in experimental cirrhosis. Life Sciences 2020; 257 doi: 10.1016/j.lfs.2020.118111
|
| 16 |
Mauro Bernardi, Richard Moreau, Paolo Angeli, Bernd Schnabl, Vicente Arroyo. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. Journal of Hepatology 2015; 63(5) doi: 10.1016/j.jhep.2015.07.004
|
| 17 |
Kirsten E. Pijls, Daisy M. A. E. Jonkers, Elhaseen E. Elamin, Ad A. M. Masclee, Ger H. Koek. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Liver International 2013; 33(10) doi: 10.1111/liv.12271
|
| 18 |
Kristina Norman, Matthias Pirlich. Gastrointestinal tract in liver disease: which organ is sick?. Current Opinion in Clinical Nutrition & Metabolic Care 2008; 11(5) doi: 10.1097/MCO.0b013e32830a70bc
|
| 19 |
Swati Chouhan, Prajna Anirvan, Shivaram Prasad Singh. Pharmacotherapy for Liver Cirrhosis and Its Complications. 2022; doi: 10.1007/978-981-19-2615-0_4
|
| 20 |
Kathleen Yan, Guadalupe Garcia-Tsao. Novel prevention strategies for bacterial infections in cirrhosis. Expert Opinion on Pharmacotherapy 2016; 17(5) doi: 10.1517/14656566.2016.1145663
|
| 21 |
Bridget P. Keenan, Lawrence Fong, Robin K. Kelley. Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0749-z
|
| 22 |
Reiner Wiest, Melissa Lawson, Markus Geuking. Pathological bacterial translocation in liver cirrhosis. Journal of Hepatology 2014; 60(1) doi: 10.1016/j.jhep.2013.07.044
|
| 23 |
Tim Hendrikx, Bernd Schnabl. Antimicrobial proteins: intestinal guards to protect against liver disease. Journal of Gastroenterology 2019; 54(3) doi: 10.1007/s00535-018-1521-8
|
| 24 |
|
| 25 |
Kenta Yamamoto, Takashi Honda, Takanori Ito, Yoji Ishizu, Teiji Kuzuya, Masanao Nakamura, Ryoji Miyahara, Hiroki Kawashima, Masatoshi Ishigami, Mitsuhiro Fujishiro. The relationship between oral‐origin bacteria in the fecal microbiome and albumin–bilirubin grade in patients with hepatitis C. Journal of Gastroenterology and Hepatology 2021; 36(3) doi: 10.1111/jgh.15206
|
| 26 |
Dalilah Restrepo, Shirish S. Huprikar, Kenneth VanHorn, Edward J. Bottone. O1 and non-O1 Vibrio cholerae bacteremia produced by hemolytic strains. Diagnostic Microbiology and Infectious Disease 2006; 54(2) doi: 10.1016/j.diagmicrobio.2005.08.008
|
| 27 |
Veronika Rackayová, Emmanuelle Flatt, Olivier Braissant, Jocelyn Grosse, Daniela Capobianco, Paola Mastromarino, Matthew McMillin, Sharon DeMorrow, Valérie A. McLin, Cristina Cudalbu. Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81871-8
|
| 28 |
Feng Liu, Ji Xin Li, Chun Mei Li, Xi Sheng Leng. Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients. World Journal of Gastroenterology 2001; 7(1): 126-127 doi: 10.3748/wjg.v7.i1.126
|
| 29 |
Chien-Fu Hsu, Chia-Chang Huang, Tze-Tze Liu, Ueng-Cheng Yang, Chih-Wei Liu, Shiang-Fen Huang, Ying-Ying Yang, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin. Deletion of intestinal SIRT1 exacerbated muscle wasting in cirrhotic mice by decreasing the intestinal concentration of short-chain fatty acids and inflammation. Journal of Pharmacological Sciences 2021; 147(4) doi: 10.1016/j.jphs.2021.09.003
|
| 30 |
María Martínez-Esparza, María Tristán-Manzano, Antonio J Ruiz-Alcaraz, Pilar García-Peñarrubia. Inflammatory status in human hepatic cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11522-11541 doi: 10.3748/wjg.v21.i41.11522
|
| 31 |
C. Rose, A. Parker, B. Jefferson, E. Cartmell. The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology. Critical Reviews in Environmental Science and Technology 2015; 45(17) doi: 10.1080/10643389.2014.1000761
|
| 32 |
Aiman Ghufran. Nutrition in Chronic Liver Disease: A Point‐of‐Care Review. Nutrition in Clinical Practice 2020; 35(2) doi: 10.1002/ncp.10470
|
| 33 |
Mercedes Márquez, Clotilde Fernández Gutiérrez del Álamo, José Antonio Girón-González. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. World Journal of Gastroenterology 2016; 22(4): 1433-1448 doi: 10.3748/wjg.v22.i4.1433
|
| 34 |
Vincent Di Martino, Caroline Coutris, Jean‐Paul Cervoni, Stavros Dritsas, Delphine Weil, Carine Richou, Claire Vanlemmens, Thierry Thevenot. Prognostic value of C‐reactive protein levels in patients with cirrhosis. Liver Transplantation 2015; 21(6) doi: 10.1002/lt.24088
|
| 35 |
Chathur Acharya, Sinem Esra Sahingur, Jasmohan S. Bajaj. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI Insight 2017; 2(19) doi: 10.1172/jci.insight.94416
|
| 36 |
Tamara Milovanović, Vladimir Nikolić. The influence of bacterial infections on the course and outcome of patients with liver cirrhosis: Prophylaxis and treatment. Medicinska istrazivanja 2017; 51(3) doi: 10.5937/MedIst1703001M
|
| 37 |
Reiner Wiest, Guadalupe Garcia‐Tsao. Bacterial translocation (BT) in cirrhosis†. Hepatology 2005; 41(3) doi: 10.1002/hep.20632
|
| 38 |
B. Sharmila Mohanraj, Amol S. Rangnekar, Joseph G. Timpone. Principles and Practice of Transplant Infectious Diseases. 2019; doi: 10.1007/978-1-4939-9034-4_3
|
| 39 |
Guo-Qing Zuo, Jian-Ping Gong, Chang-An Liu, Shen-Wei Li, Xin-Chuan Wu, Kang Yang, Yue Li. Expression of lipopolysaccharide binding protein and its receptor CD14 in experimental alcoholic liver disease. World Journal of Gastroenterology 2001; 7(6): 836-840 doi: 10.3748/wjg.v7.i6.836
|
| 40 |
Hiroshi Fukui, Reiner Wiest. Changes of Intestinal Functions in Liver Cirrhosis. Inflammatory Intestinal Diseases 2016; 1(1) doi: 10.1159/000444436
|